NASDAQ: ORKA
Oruka Therapeutics Inc Stock Ownership - Who owns Oruka Therapeutics?

Insider buying vs selling

Have Oruka Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul T. QuinlanCLO2026-09-212,667$95.31
$254.19kSell
Arjun AgarwalSVP2026-09-21533$95.75
$51.03kSell
Paul T. QuinlanCLO2026-09-2110,000$7.80
$78.00kBuy
Paul T. QuinlanCLO2026-09-212,900$92.37
$267.87kSell
Paul T. QuinlanCLO2026-09-213,832$93.32
$357.59kSell
Paul T. QuinlanCLO2026-09-21601$94.44
$56.76kSell
Joana GoncalvesMed2026-09-15947$95.71
$90.64kSell
Joana GoncalvesMed2026-09-153,500$6.84
$23.94kBuy
Joana GoncalvesMed2026-09-153,500$7.80
$27.30kBuy
Joana GoncalvesMed2026-09-152,384$91.10
$217.17kSell

1 of 15

ORKA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORKA insiders and whales buy or sell their stock.

ORKA Shareholders

What type of owners hold Oruka Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Krishna Kittu Kolluri15.44%10,221,465$860.55MInsider
Peter J. Barris15.44%10,221,465$860.55MInsider
Forest Baskett15.44%10,221,465$860.55MInsider
Anthony A. Florence Jr.15.44%10,221,465$860.55MInsider
Peter W. Sonsini15.44%10,221,465$860.55MInsider
Harry R. Weller15.44%10,221,465$860.55MInsider
Ravi Viswanathan15.44%10,221,465$860.55MInsider
Joshua Makower15.44%10,221,465$860.55MInsider
David M. Mott15.44%10,221,465$860.55MInsider
Jon Sakoda15.44%10,221,465$860.55MInsider

1 of 3

ORKA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORKA0.05%99.95%Net SellingNet Selling
PTCT0.12%18.83%Net SellingNet Selling
CRSP0.08%35.64%Net SellingNet Buying
COGT0.11%8.01%Net SellingNet Buying
TVTX0.11%61.52%Net SellingNet Selling

Oruka Therapeutics Stock Ownership FAQ

Who owns Oruka Therapeutics?

Oruka Therapeutics (NASDAQ: ORKA) is owned by 0.11% institutional shareholders, 232.46% Oruka Therapeutics insiders, and 0.00% retail investors. Krishna Kittu Kolluri is the largest individual Oruka Therapeutics shareholder, owning 10.22M shares representing 15.44% of the company. Krishna Kittu Kolluri's Oruka Therapeutics shares are currently valued at $839.69M.

If you're new to stock investing, here's how to buy Oruka Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.